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Objective: The role of B cells in the pathogenesis of Takayasu arteritis (TA) is controversial. We aimed to study the presence of tertiary lymphoid organs (TLOs) in the aortic wall of TA patients.
Methods: Hematoxylin and eosin-stained sections from aorta specimens from patients with TA were screened for TLOs. The presence of B cell aggregates (CD20), follicular dendritic cells (FDCs, CD21), and high endothelial venules (HEVs, PNAd) was investigated by immunohistochemistry. Immune cells from the adventitial layer of one patient were characterized by flow cytometry. Demographic, medical history, laboratory, imaging, treatment, and follow-up data were extracted from medical records.
results: Aorta specimens from Bentall procedures were available from seven patients (5 females, aged 22-57 years) with TA. Surgical treatment was performed at TA diagnosis (n = 4) or at a median of 108 months (84-156) after TA diagnosis. Disease was active at surgery in four patients according to NIH score. B cell aggregates-TLOs containing HEVs were observed in the adventitia of all but one patient. Of note, ectopic follicles containing CD21 + FDCs were found in all patients (4/4) with increased aortic BMI, body mass index; the type of aortic lesions was defined according to international criteria (14) ; the disease activity score was assessed according to NIH criteria (12) . Systemic features referred to fatigue (n = 4), headache (n = 2), weight loss (n = 1), dizziness (n = 1), arthritis (n = 1), visual disturbance (n = 1), or erythema nodosum (n = 1). Vascular features referred to carotid or subclavian bruit (n = 4), claudication with a diminished or absent pulse (n = 4) and carotidodynia (n = 2). inTrODUcTiOn Takayasu arteritis (TA) is a rare primary vasculitis affecting large arteries, especially the aorta, the aortic arch, and its main branches. The etiology of TA is unknown even if it has been proposed that infectious agents play a significant role in the pathogenesis of this disease (1) . In addition, while T cells exhibiting a Th1 profile have been implicated in the pathogenesis of TA (1, 2), the role of humoral immunity remains to be elucidated. Tertiary lymphoid organs (TLOs) are ectopic lymphoid structures that form at sites of chronic inflammation through a process referred as lymphoid neogenesis. TLOs have morphologic features of secondary lymphoid organs including post-capillary high endothelial venules (HEVs) allowing homing of naive cells in the T cell area, an interface between T and B cell zones and germinal center (GC) areas. TLOs have been described in autoimmunity, microbial infection, cancer, chronic allograft rejection, atherosclerosis models, and abdominal aortic aneurysms (3) (4) (5) . Studies have pinpointed the presence of lymphoid aggregates in the aortic wall of TA patients without distinguishing them from granulomas and have suggested their implication in the physiopathology of TA (6, 7) . In addition, pathogenic B cells producing autoantibodies against endothelial cells are found in the blood stream of active TA patients, which suggests that these B cells could be activated within the adventitial layer before recirculating (8) . Finally, some TA patients with active disease have a dramatic increase of circulating plasmablasts that are efficiently targeted by depleting anti-CD20 antibodies (9) .
We aimed at characterizing the peri-aortic lymphoid aggregates developing in TA patients and at analyzing whether their presence could be associated with the activity of the disease.
MaTerials anD MeThODs

Patients
We conducted a retrospective multicenter study of patients with TA in whom aortic surgery was performed and aortic tissue specimen was available for analysis. All patients fulfilled the American College of Rheumatology and the Sharma-modified Ishikawa criteria for TA (10, 11) . Demographic, medical history, laboratory, imaging findings, including 18 F-fluoro-deoxyglucose positron emission tomography (FDG-PET), computed tomography angiography (CTA), and/or magnetic resonance imaging (MRI), treatment, and follow-up data were extracted from medical records. The patients' clinical, laboratory, and imaging data, as well as treatments were analyzed at disease onset and at time of surgery. Routine laboratory tests, including C-reactive protein levels, were collected, and disease activity was defined according to the NIH criteria (12) . Disease was considered active if NIH score was 2 or more, and inactive otherwise.
immunohistochemistry on aortic samples
Aorta tissues were fixed in 4% PFA, embedded in paraffin, and sectioned at 6 μm. The sections were deparaffinized in toluene, hydrated in ethanol, and incubated in retrieval reagent (R&D Systems) for 20 min. After blocking in 5% BSA, the slides were incubated with purified primary antibody (mouse anti-human CD20, clone L-26; rabbit anti-human CD3, polyclonal, Dako; rat anti-human PNAd, MECA-79, BD Biosciences; rabbit anti-human CD14, clone EPR3653; rabbit anti-human CD21, clone EP3093, Abcam; mouse anti-human CD15, clone HI98, Biolegend) overnight at 4°C. After several washes with PBS, sections were incubated with the appropriate secondary antibody (polyclonal goat anti-rabbit DyLight649; goat anti-mouse rhodamine; goat anti-rat rhodamine; donkey anti-mouse rhodamine, Jackson Immunoresearch) at RT for 30 min and then cover mounted using Prolong Gold Antifade Reagent ® (Invitrogen) for microscopy. The resulting fluorescence was detected with a Zeiss Axiovert 200 M microscope equipped with an AxioCam MRm version 3 camera, an ApoTome ® system, and AxioVision ® image capture software.
Flow cytometry analysis
Adventitial layer samples from the aorta were weighed, cut into small pieces (<1 mm), and digested using a previously described protocol (13) . After a wash step, the cells were incubated with 
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resUlTs
Patients' characteristics at Disease Onset and Medical Treatment
Aorta specimens were available from 16 patients with TA who underwent surgery between 2009 and 2014. Nine patients were excluded because diagnosis criteria for TA were not met (n = 7) or data were missing (n = 2). Seven patients (five females and two males) who fulfilled American College of Rheumatology and Ishikawa criteria for TA were studied. The median age at TA diagnosis was 34 years (22-57). Diabetes mellitus and dyslipidemia were present in cases 1 (14.3%) and 2 (28.6%), respectively. Tobacco use was reported in four (57.1%) patients. No patients had past history of tuberculosis. The median body mass index was 23.5 kg/m 2 (21.1-33.3). The country of origin was France (n = 4), Morocco (n = 1), Mali (n = 1), and West Congo (n = 1).
At disease onset, patients suffered from fatigue (n = 4), headache (n = 2), carotidodynia (n = 2), weight loss (n = 1), dizziness (n = 1), arthritis (n = 1), visual disturbance (n = 1), and erythema nodosum (n = 1). No patients had fever. One patient was asymptomatic but had asymmetric blood pressure. Hypertension was present at onset (n = 4) or occurred (n = 1) during the course of the disease. The median delay between the onset of first symptoms and the diagnosis of disease was 29 months (3-96).
Serum C-reactive protein levels were raised in five (71.4%) patients [median 68 mg/L (11-106)]. At TA diagnosis, disease was considered active (NIH score ≥2) in all patients. CT angiography of the aorta was performed at TA diagnosis and showed multiple arterial lesions in all patients. Aorta was involved in all cases ( Table 1) .
All patients received glucocorticoids as first-line treatment. Methotrexate (n = 3), infliximab (n = 2), azathioprine (n = 1), and tocilizumab (n = 1) were prescribed during follow-up in four patients.
Patients' characteristics at surgery
Surgery was performed at the time of first diagnosis in four patients or during follow-up (84-156 months) in three patients. Disease was active at time of surgery in four patients with a NIH score ranging from 2 to 3, including recent ischemic vascular claudication (n = 2), new upper limb bruit (n = 1), and/ or C-reactive protein >10 mg/L (n = 3). Aortic CT angiography displayed an increased circumferential aorta wall thickness (3.5-16 mm, median 7 mm). PET showed an increased FDG uptake in the vascular wall of the thoracic aorta wall in four cases. Three patients, including one with active disease, were still receiving glucocorticoids at time of surgery with a daily dose <10 mg. One patient was under tocilizumab. Antiplatelet treatment and statin were given in cases 3 and 4, respectively ( Table 2) .
Fourteen vascular procedures were done in seven patients (1-3 per patient, mean 1.7). Indications for surgery were aortic regurgitation due to thoracic aneurysm (n = 7) and abdominal aorta stenosis with lower limb chronic ischemia (n = 1).
Specimens from the thoracic aorta were obtained from Bentall procedures in all cases. At surgery, peri-aortic inflammation was obvious in five patients. Microscopically, prominent fibrosis was observed in intimal (n = 3), medial (n = 2), and adventitial (n = 7) layers, associated with increased intimal (n = 3) and adventitial (n = 5) thickness. Medial or adventitial inflammation was seen in all cases and involved mononuclear cells (n = 7), giant cells (n = 3), and plasma wall cells (n = 3). The deep portion of the media (n = 4) and adventitia (n = 2) contained neovessels. Atherosclerotic lesions were detected in two aortic specimens ( Table 2) .
Tertiary lymphoid Organs in the aortic Wall
Combination of CD14, CD20, and CD21 staining allowed identification of active TLOs (>90% CD14 
/CD15
+ granulomas (Figure 2) . Of note, the presence of TLOs in the aortic wall was associated with FDG uptake measured by PET-CT scanner (Figure 3) . Indeed, ectopic follicles containing CD21
+ follicular dendritic cells (FDCs) were found in all patients with increased aortic FDG uptake before surgery, but were absent in all but one (2/3) patients with no FDG uptake ( Table 2) .
Memory B cells and antigen-experienced T Follicular helper cells in the aortic Wall
Patient 1 (P01) had a Bentall procedure for aortic regurgitation due to thoracic aortic aneurysm ( Tables 1 and 2 
DiscUssiOn
Takayasu arteritis is a rare form of chronic large vessel vasculitis of unknown origin involving the aorta and its major branches. Over the last decades, T cell-mediated immunity and inflammation have been implicated in the pathogenesis of this disease. Our data show that ectopic lymphoid neogenesis takes place in the aortic wall of patients with active TA and highlight the role of B cells in TA.
Using immunohistochemical examination, mature TLOs were detected in the adventitia of all but one TA aortic specimen. The accumulation of B cells within the adventitia, as well as their organization in TLOs suggests that B cells infiltrate the aortic wall in TA. The structural similarities between TLOs and B cells follicles found in secondary lymphoid organs suggest a local recruitment of naive cells via HEV (PNAd + ), their activation, as well as the establishment of an immunological humoral memory supported by Tfh cells. We detected by immunostaining both TLOs and granulomas, each displaying distinct cellular composition and occupying different vascular niches. This suggests different functions and involvement in the activity of the disease with TLOs enhancing the destructive properties of granulomas and vice versa.
Analysis of immune adventitial cells revealed a high percentage of memory and antigen-experienced CD4 + T cells and also the presence of cells expressing canonical Tfh cell markers, such as CXCR5, Bcl6, and PD-1. These cells orchestrate B-cell activation, proliferation, and function (15) . TLOs development and maintenance in TA may thus depend on the Tfh cell compartment as recently reported in atherosclerosis-prone mice (5) . In addition, patients with TA are known to have enhanced interleukine-6 (IL-6) serum levels that parallel disease activity (16) and inhibition of IL-6 by the monoclonal anti-IL-6 receptor antibody tocilizumab is clearly efficient in TA (17) . Interestingly, IL-6 is essential for B and Tfh cell differentiation (18) suggesting that immunotherapy against IL-6 could have dampened TLO development in the Tertiary Lymphoid Organs in Takayasu inflamed arteries of TA patients. Thus, our data suggest that the TLOs in TA can support antigen-driven clonal expansion and diversification and contain key elements for driving an immune pathogenic response that could last for decades if long lived plasma cells and memory CD4 + T cells are generated. Tertiary lymphoid organs can develop in inflamed tissues with a frequency that varies greatly depending on the anatomical sites and diseases. Ectopic lymphoid tissue and lymphoid neogenesis have been observed in infection or immune disorders, including synovia in rheumatoid arthritis (19) , salivary glands of patients with Sjogren's syndrome (20) , multiple sclerosis, inflammatory bowel diseases, and allografts (4). Although we still do not know what antigenic stimuli trigger their formation, TLOs cannot be considered as simple passive bystander markers of tissue inflammation because they are able to promote auto-or allo-antibody production and activating cellular effectors resulting in organ damage such as chronic inflammatory disorders and allograft rejection (3, 4) .
In conclusion, TLOs are detected in the aortic adventitia of TA and comprise Tfh cells, clearly implicating B-cells in active TA. Deciphering whether TLOs are functional and allow the
